Last update :
07/04/2025
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Anticancer drug   Idarubicin hydrochloride  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Idacrybin Mexico
Idamen Turkey
Idamycin Canada, Mexico, United States of America
Idaralem Colombia
Ondarubin Mexico
Rubixina Peru
Zavedos Australia, Austria, Belgium, Brazil, Chile, Colombia, Croatia, Denmark, Ecuador, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Iran, Ireland, Italy, Luxembourg, Malaysia, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden, Tunisia, Turkey, Venezuela
Stability in solutions   injection   Stability in solutions : Idarubicin hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Polypropylene NaCl 0,9% or Glucose 5% 0,1 mg/ml 25°C Protect from light
28 Day
632
Level of evidence C
Polypropylene Ringer’s lactate solution 0,1 mg/ml 25°C Protect from light
28 Day
632
Level of evidence C
Polypropylen Syringe Water for Injection 4 mg/ml 2-8°C Protect from light
7 Day
4661
Level of evidence A
  Mentions Légales